Scotto R - Search Results

1

Risk Factors for Pneumocystis jirovecii Pneumonia in Non-HIV Patients Hospitalized for COVID-19: A Case-Control Study.

Viceconte G, Buonomo AR, D'Agostino A, Foggia M, Di Fusco A, Pinchera B, Scotto R, Iacovazzo C, Fanasca L, Messina G, Cacciatore F, Salvatore P, Gentile I, On Behalf Of The Federico Ii Covid Team. Viceconte G, et al. Among authors: scotto r. J Fungi (Basel). 2023 Aug 11;9(8):838. doi: 10.3390/jof9080838. J Fungi (Basel). 2023. PMID: 37623609 Free PMC article.

2

Comparison of Central Corneal Thickness Measurements Using Ultrasonic Pachymetry, Anterior Segment OCT and Noncontact Specular Microscopy.

Scotto R, Bagnis A, Papadia M, Cutolo CA, Risso D, Traverso CE. Scotto R, et al. J Glaucoma. 2017 Oct;26(10):860-865. doi: 10.1097/IJG.0000000000000745. J Glaucoma. 2017. PMID: 28834824

3

Corneal graft dellen in a patient implanted with a Boston keratoprosthesis type 1.

Scotto R, Vagge A, Traverso CE. Scotto R, et al. Int Ophthalmol. 2017 Feb;37(1):263-266. doi: 10.1007/s10792-016-0227-2. Epub 2016 Apr 11. Int Ophthalmol. 2017. PMID: 27068827

4

Recommendations Concerning the First-Line Treatment of Children with Tuberculosis.

Principi N, Galli L, Lancella L, Tadolini M, Migliori GB, Villani A, Esposito S; Italian Pediatric TB Study Group. Principi N, et al. Paediatr Drugs. 2016 Feb;18(1):13-23. doi: 10.1007/s40272-015-0155-z. Paediatr Drugs. 2016. PMID: 26612773 Review.

5

Rarebit perimetry and frequency doubling technology in patients with ocular hypertension.

Corallo G, Iester M, Scotto R, Calabria G, Traverso CE. Corallo G, et al. Among authors: scotto r. Eur J Ophthalmol. 2008 Mar-Apr;18(2):205-11. doi: 10.1177/112067210801800207. Eur J Ophthalmol. 2008. PMID: 18320512

6

Learning effect in perimetry: the role of chromatic discrimination.

Bagnis A, Corallo G, Scotto R, Iester M. Bagnis A, et al. Among authors: scotto r. Am J Ophthalmol. 2011 Dec;152(6):1075-6; author reply 1076. doi: 10.1016/j.ajo.2011.09.002. Am J Ophthalmol. 2011. PMID: 22107932 No abstract available.

7

Current and emerging medical therapies in the treatment of glaucoma.

Bagnis A, Papadia M, Scotto R, Traverso CE. Bagnis A, et al. Among authors: scotto r. Expert Opin Emerg Drugs. 2011 Jun;16(2):293-307. doi: 10.1517/14728214.2011.563733. Epub 2011 Apr 7. Expert Opin Emerg Drugs. 2011. PMID: 21406029 Review.

8

Obstruction of the Ex-PRESS miniature glaucoma device: Nd: YAG laser as a therapeutic option.

Bagnis A, Papadia M, Scotto R, Traverso CE. Bagnis A, et al. Among authors: scotto r. J Glaucoma. 2011 Apr-May;20(4):271. doi: 10.1097/IJG.0b013e3182127984. J Glaucoma. 2011. PMID: 21430552 No abstract available.

9

Efficacy and safety of a steel drainage device implanted under a scleral flap.

De Feo F, Bagnis A, Bricola G, Scotto R, Traverso CE. De Feo F, et al. Among authors: scotto r. Can J Ophthalmol. 2009 Aug;44(4):457-62. doi: 10.3129/i09-120. Can J Ophthalmol. 2009. PMID: 19606171

10

Antiglaucoma drugs: The role of preservative-free formulations.

Bagnis A, Papadia M, Scotto R, Traverso CE. Bagnis A, et al. Among authors: scotto r. Saudi J Ophthalmol. 2011 Oct;25(4):389-94. doi: 10.1016/j.sjopt.2011.08.004. Epub 2011 Aug 28. Saudi J Ophthalmol. 2011. PMID: 23960953 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

119 results

Search Page